Corporate America has posted 14 quarters of double-digit earnings growth. But in this earnings season analysts predict S&P 500 companies will report only about 3.5% growth. And analysts say that's OK. Amy Scott reports.
Biologics are the most expensive pharmaceuticals on the market, but you never see them advertised. This week, the FDA announced more research is needed for possible cheaper generic versions. Andrea Smardon reports.